LUPIN | PANCHSHEEL ORG | LUPIN/ PANCHSHEEL ORG |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 35.1 | 19.9 | 176.4% | View Chart |
P/BV | x | 6.6 | 2.3 | 289.6% | View Chart |
Dividend Yield | % | 0.4 | 1.5 | 25.7% |
LUPIN PANCHSHEEL ORG |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
LUPIN Mar-24 |
PANCHSHEEL ORG Mar-24 |
LUPIN/ PANCHSHEEL ORG |
5-Yr Chart Click to enlarge
|
||
High | Rs | 1,704 | 229 | 745.6% | |
Low | Rs | 645 | 160 | 402.9% | |
Sales per share (Unadj.) | Rs | 439.8 | 79.9 | 550.5% | |
Earnings per share (Unadj.) | Rs | 42.5 | 10.7 | 397.1% | |
Cash flow per share (Unadj.) | Rs | 68.8 | 12.0 | 572.2% | |
Dividends per share (Unadj.) | Rs | 8.00 | 3.28 | 243.9% | |
Avg Dividend yield | % | 0.7 | 1.7 | 40.3% | |
Book value per share (Unadj.) | Rs | 311.6 | 94.9 | 328.2% | |
Shares outstanding (eoy) | m | 454.98 | 13.17 | 3,454.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 2.7 | 2.4 | 109.8% | |
Avg P/E ratio | x | 27.6 | 18.1 | 152.2% | |
P/CF ratio (eoy) | x | 17.1 | 16.1 | 105.6% | |
Price / Book Value ratio | x | 3.8 | 2.0 | 184.2% | |
Dividend payout | % | 18.8 | 30.6 | 61.4% | |
Avg Mkt Cap | Rs m | 534,250 | 2,559 | 20,880.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 34,946 | 65 | 53,376.7% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 200,108 | 1,052 | 19,018.3% | |
Other income | Rs m | 1,416 | 25 | 5,760.0% | |
Total revenues | Rs m | 201,524 | 1,077 | 18,715.6% | |
Gross profit | Rs m | 37,891 | 189 | 20,009.0% | |
Depreciation | Rs m | 11,968 | 17 | 68,821.7% | |
Interest | Rs m | 3,116 | 3 | 116,272.4% | |
Profit before tax | Rs m | 24,223 | 194 | 12,493.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 4,867 | 53 | 9,216.1% | |
Profit after tax | Rs m | 19,356 | 141 | 13,719.7% | |
Gross profit margin | % | 18.9 | 18.0 | 105.2% | |
Effective tax rate | % | 20.1 | 27.2 | 73.8% | |
Net profit margin | % | 9.7 | 13.4 | 72.1% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 134,477 | 1,071 | 12,551.1% | |
Current liabilities | Rs m | 85,015 | 339 | 25,096.7% | |
Net working cap to sales | % | 24.7 | 69.6 | 35.5% | |
Current ratio | x | 1.6 | 3.2 | 50.0% | |
Inventory Days | Days | 26 | 126 | 20.8% | |
Debtors Days | Days | 86 | 1,369 | 6.3% | |
Net fixed assets | Rs m | 102,470 | 558 | 18,357.5% | |
Share capital | Rs m | 911 | 132 | 691.9% | |
"Free" reserves | Rs m | 140,847 | 1,119 | 12,591.0% | |
Net worth | Rs m | 141,758 | 1,250 | 11,337.5% | |
Long term debt | Rs m | 0 | 3 | 0.0% | |
Total assets | Rs m | 236,947 | 1,630 | 14,540.0% | |
Interest coverage | x | 8.8 | 73.3 | 12.0% | |
Debt to equity ratio | x | 0 | 0 | 0.0% | |
Sales to assets ratio | x | 0.8 | 0.6 | 130.8% | |
Return on assets | % | 9.5 | 8.8 | 107.5% | |
Return on equity | % | 13.7 | 11.3 | 121.0% | |
Return on capital | % | 19.3 | 15.7 | 122.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 74,341 | 0 | - | |
Fx outflow | Rs m | 22,943 | 0 | - | |
Net fx | Rs m | 51,399 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 36,484 | 96 | 38,122.9% | |
From Investments | Rs m | -17,122 | -72 | 23,724.5% | |
From Financial Activity | Rs m | -21,842 | 160 | -13,625.8% | |
Net Cashflow | Rs m | -2,481 | 184 | -1,349.3% |
Indian Promoters | % | 46.7 | 56.1 | 83.2% | |
Foreign collaborators | % | 0.3 | 0.0 | - | |
Indian inst/Mut Fund | % | 46.6 | 1.1 | 4,087.7% | |
FIIs | % | 21.5 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 53.0 | 43.9 | 120.9% | |
Shareholders | 279,280 | 7,854 | 3,555.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare LUPIN With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB MANKIND PHARMA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Lupin | PANCHSHEEL ORG | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 0.31% | -1.55% | 0.11% |
1-Month | -4.92% | -5.85% | -3.22% |
1-Year | 67.15% | 17.40% | 42.65% |
3-Year CAGR | 32.87% | 29.39% | 19.86% |
5-Year CAGR | 21.53% | 50.95% | 25.90% |
* Compound Annual Growth Rate
Here are more details on the Lupin share price and the PANCHSHEEL ORG share price.
Moving on to shareholding structures...
The promoters of Lupin hold a 47.0% stake in the company. In case of PANCHSHEEL ORG the stake stands at 56.1%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Lupin and the shareholding pattern of PANCHSHEEL ORG.
Finally, a word on dividends...
In the most recent financial year, Lupin paid a dividend of Rs 8.0 per share. This amounted to a Dividend Payout ratio of 18.8%.
PANCHSHEEL ORG paid Rs 3.3, and its dividend payout ratio stood at 30.6%.
You may visit here to review the dividend history of Lupin, and the dividend history of PANCHSHEEL ORG.
For a sector overview, read our pharmaceuticals sector report.
On Thursday, Indian share markets traded lower throughout the trading session and ended on a weak note.